Are herbal remedies and dietary supplements safe and effective for breast cancer patients?

Breast Cancer Research

Volumn 5, Issue 6, 2003, Pages 300-302

  Cassidy, Aedin ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Breast cancer; Dietary; Herbal; Supplements

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; ISOFLAVONE; PHYTOESTROGEN; PLANT EXTRACT;

ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER PATIENT; DIET SUPPLEMENTATION; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; HERBAL MEDICINE; HUMAN; INTERPERSONAL COMMUNICATION; PRESCRIPTION; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; SIDE EFFECT;

BREAST NEOPLASMS; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MEDICINE, HERBAL; PHYTOTHERAPY;

EID: 0242609038     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr724     Document Type: Article

References (18)

1. Mills E, Ernst E, Singh R, Ross C, Wilson K: Health food store recommendations: implications for breast cancer patients. Breast Cancer Res 2003, 5:R170-R174.
2. Gotay CC, Dumitriu D: Health Food store recommendations for breast cancer patients. Arch Fam Med 2000, 9:692-699.
3. Stoffer S, Szpunar W, Coleman B, Mallos P: Advice from some health food stores. JAMA 1980, 244:2044-2046.
4. US Food and Drug Administration: Unsubstantiated Claims and Documented Health Hazards in the Dietary Supplements Market-place. USA: Food and Drug Administration; 1993.
5. Writing Group of the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principle results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288: 321-333.
6. Million Women Study Collaborators: Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003, 362:419-427.
7. Morris KT, Johnson N, Homer L, Walts D: A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 2000, 179: 407-411.
8. Ernst E, Cassileth BR: The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998, 83:777-782.
9. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D: Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 2000, 92:42-47.
10. Spaulding-Albright N: A review of some herbal and related products commonly used in cancer patients. J Am Diet Assoc 1997, Suppl 2:S208-215.
11. Mathijssen RH, Verweij J, De Bruijn P, Loos WJ, Sparreboom A: Effects of St. John's Wort on irinotecan metabolism. J Natl Cancer Inst 2002, 94:1247-1249.
12. Adler SR, Fosket JR: Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract 1999, 48:453-458.
13. Kaegi E: Unconventional therapies for cancer: 1. Essiac. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ 1998, 158:897-902.
14. Miller DR, Anderson GT, Stark JJ, Granick JL, Richardson D: Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998, 16: 3649-3655.
15. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE: Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001, Suppl:1362S-1375S.
16. US Food and Drug Administration: Risk of drug interactions with St. John's Wort. JAMA 2000, 283:1679.
17. Izzo AA, Ernst E: Interactions between herbal medicines and prescribed drugs:a systematic review. Drugs 2001, 61:2163-2175.
18. US Food and Drug Administration: Letter to Health Care Professionals. FDA Issues Consumer Advisory that Kava Products may be Associated with Severe Liver Injury. USA: US Food and Drug Administration, Office of Nutritional Products, Labelling and Dietary Supplements; 2002.